Northwestern Mutual Wealth Management CO Glaukos Corp Transaction History

Northwestern Mutual Wealth Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$76.4 - $96.33 $4,736 - $5,972	-62 Reduced 92.54%	5 $0
Q4 2023 Feb 13, 2024	BUY	$59.53 - $85.11 $3,988 - $5,702	67 New	67 $5,000
Q2 2022 Aug 04, 2022	SELL	$34.86 - $63.77 $8,645 - $15,814	-248 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$44.33 - $57.82 $10,993 - $14,339	248 New	248 $14,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.